These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2683408)

  • 61. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
    Augustine JA; Zemaitis MA
    Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of microsomal metabolism and chemical oncogenesis in culture by naphthalene quinones.
    Nesnow S; Bergman H; Garland H; Morris M
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):17-30. PubMed ID: 7217845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between activities of cytochrome P-450 monooxygenases in human placental microsomes and binding of benzo(a)pyrene metabolites to calf thymus DNA.
    Kim SY; Chung JH; Kang KW; Joe CO; Park KH
    Drug Chem Toxicol; 1992; 15(4):313-27. PubMed ID: 1459043
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60.
    Ueng TH; Kang JJ; Wang HW; Cheng YW; Chiang LY
    Toxicol Lett; 1997 Sep; 93(1):29-37. PubMed ID: 9381480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A selective decrease in the xenobiotic metabolizing activity of rat lungs by nitrogen dioxide exposures.
    Takahashi Y; Miura T
    Toxicology; 1989 Mar; 54(3):281-96. PubMed ID: 2495581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal.
    Hétu C; Joly JG
    Biochem Pharmacol; 1985 Apr; 34(8):1211-6. PubMed ID: 3873242
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
    Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH
    Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450.
    Chapman DE; Holbrook DJ; Chaney SG; Hall IH; Lee KH
    Biochem Pharmacol; 1991 Jan; 41(2):229-35. PubMed ID: 1989634
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug metabolism in the Novikoff hepatoma: evidence for a mixed function oxidase system and partial purification of cytochrome P-450 reductase.
    Saine SE; Fang WF; Strobel HW
    Biochim Biophys Acta; 1978 Oct; 526(2):345-58. PubMed ID: 718941
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
    Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
    Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of caffeine on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo[a]pyrene treatment in rats.
    Govindwar SP; Kachole MS; Pawar SS
    Toxicol Lett; 1988 Aug; 42(2):109-15. PubMed ID: 3406955
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction of xenobiotic biotransformation by the insecticide chlordimeform, a metabolite 4-chloro-o-toluidine and a structurally related chemical o-toluidine.
    Leslie C; Reidy GF; Murray M; Stacey NH
    Biochem Pharmacol; 1988 Jul; 37(13):2529-35. PubMed ID: 3390215
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Two cytochrome P-450 isoforms catalysing O-de-ethylation of ethoxycoumarin and ethoxyresorufin in higher plants.
    Werck-Reichhart D; Gabriac B; Teutsch H; Durst F
    Biochem J; 1990 Sep; 270(3):729-35. PubMed ID: 2241905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of arsenite on hepatic mixed-function oxidase activity in rats.
    Albores A; Cebrian ME; Connelly JC; Bach PH; Bridges JW
    Xenobiotica; 1992 May; 22(5):591-7. PubMed ID: 1413874
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Monoclonal antibody-directed analysis of cytochrome P-450-dependent monooxygenases and mutagen activation in the livers of DBA/2 and C57BL/6 mice.
    Hietanen E; Malaveille C; Friedman FK; Park SS; Béréziat JC; Brun G; Bartsch H; Gelboin HV
    Cancer Res; 1986 Feb; 46(2):524-31. PubMed ID: 3510075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Catalytic and immunochemical characterization of hepatic microsomal cytochromes P450 in beluga whale (Delphinapterus leucas).
    White RD; Hahn ME; Lockhart WL; Stegeman JJ
    Toxicol Appl Pharmacol; 1994 May; 126(1):45-57. PubMed ID: 8184432
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The properties of cytochrome P-450 and hydroxylase activity of reconstituted proteoliposomal membranes.
    Archakov A; Bachmanova G; Karuzina I; Mengazetdinov D
    Acta Biol Med Ger; 1979; 38(2-3):299-306. PubMed ID: 517003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.